Startseite Naturwissenschaften Bioavailability of 99mTc-paclitaxel-glucuronide (99mTc-PAC-G)
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Bioavailability of 99mTc-paclitaxel-glucuronide (99mTc-PAC-G)

  • Fazilet Zumrut Biber Muftuler , Ilknur Demir , P. Ünak , Cigdem Ichedef und Ayfer Yurt Kilcar
Veröffentlicht/Copyright: 7. Februar 2011

Abstract

An antitumor agent paclitaxel (PAC) has been proved to be efficient in the treatment of breast and ovarian cancer. Glucuronic acid-derived paclitaxel compound [paclitaxel-glucuronide (PAC-G)] was enzymatically synthesized using microsome preparate separated from rat livers. The biodistribution mechanism of PAC-G in healthy female Albino Wistar rats has been investigated. The expected structure is confirmed according to LC/MS results, and the possible attachment is to C2-hydroxyl group. PAC-G was labeled with 99mTc and the radiochemical yield of radiolabeled compound (99mTc-PAC-G) was 98.0±02.74 (n=9). The range of the breast/blood and breast/muscle ratios is approximately between 3 and 35 in 240ߙmin. All these experimental studies indicate that 99mTc-PAC-G may potentially be used in breast tissue as an imaging agent.


* Correspondence address: Ege University, Department of Nuclear Applications, Institute of Nuclear Sciences, Department of Nuclear Applications, 35100 Bornova, Izmir, Türkei,

Published Online: 2011-02-07
Published in Print: 2011-05

© by Oldenbourg Wissenschaftsverlag, 35100 Bornova, Izmir, Germany

Heruntergeladen am 8.12.2025 von https://www.degruyterbrill.com/document/doi/10.1524/ract.2011.1827/html
Button zum nach oben scrollen